« Back to Record
Citation APA

Viale, G., de Snoo, F. F., Slaets, L., Bogaerts, J., van ’t Veer, L. L., Rutgers, E. T., Piccart-Gebhart, M., Stork-Sloots, L., Glas, A. M., Russo, L., Dell’Orto, P., Tryfonidis, K., Litière, S., & Cardoso, F. (2018). Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial. Breast cancer research and treatment, 167(1), 123-131. doi:10.1007/s10549-017-4509-9


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/276765

Viale, G., de Snoo, F. F., Slaets, L., Bogaerts, J., van ’t Veer, L. L., Rutgers, E. T., Piccart-Gebhart, M., Stork-Sloots, L., Glas, A. M., Russo, L., Dell’Orto, P., Tryfonidis, K., Litière, S., & Cardoso, F. (2018). Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial. Breast cancer research and treatment, 167(1), 123-131. doi:10.1007/s10549-017-4509-9